1: Keijzers GB. Aviptadil (Senatek). Curr Opin Investig Drugs. 2001 Apr;2(4):545-9. 29(6):8109-8125. doi: 10.1007/s11356-021-17824-5. Epub 2021 Nov 30. 3: Boesing M, Abig K, Brändle M, Brutsche M, Burri E, Frye BC, Giezendanner S, Grutters JC, Haas P, Heisler J, Jaun F, Leuppi-Taegtmeyer AB, Lüthi-Corridori G, Müller-Quernheim J, Nüesch R, Pohl W, Rassouli F, Leuppi JD. Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial. Trials. 2022 Sep 20;23(1):790. doi: 10.1186/s13063-022-06723-w. 4: Auld SC. Aviptadil for COVID-19: A Case Study and Call to Action About the Challenges of Research During a Global Pandemic. Crit Care Med. 2022 Nov 1;50(11):1662-1664. doi: 10.1097/CCM.0000000000005686. Epub 2022 Oct 13.